N,N-dimethylsphingosine

N,N-dimethylsphingosine is a lipid of Sphingolipids (SP) class. N,n-dimethylsphingosine is associated with abnormalities such as Exanthema and Increased drug resistance. The involved functions are known as Vmax, Metabolic Inhibition, Anabolism, Binding (Molecular Function) and Cytokinesis. N,n-dimethylsphingosine often locates in yolk, Membrane, CNS - Brain (MMHCC), soluble and Tissue membrane. The associated genes with N,N-dimethylsphingosine are FPR1 gene, ANP32A gene, HPGDS gene, Nuclear phosphoprotein and PTGS2 gene. The related lipids are Sphingolipids, Phosphatidic Acid, Lysophosphatidylcholines, stearylamine and dihydroceramide. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of N,N-dimethylsphingosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with N,N-dimethylsphingosine?

N,N-dimethylsphingosine is suspected in Exanthema, Increased drug resistance and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with N,N-dimethylsphingosine

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Asthma D001249 52 associated lipids
Proteinuria D011507 30 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Trypanosomiasis, African D014353 5 associated lipids
Total 8

PubChem Associated disorders and diseases

What pathways are associated with N,N-dimethylsphingosine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with N,N-dimethylsphingosine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with N,N-dimethylsphingosine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with N,N-dimethylsphingosine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with N,N-dimethylsphingosine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with N,N-dimethylsphingosine?

Mouse Model

Mouse Model are used in the study 'Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells.' (Habrukowich C et al., 2010).

Knock-out

Knock-out are used in the study 'Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism.' (Jin ZQ and Karliner JS, 2006).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with N,N-dimethylsphingosine

Download all related citations
Per page 10 20 50 100 | Total 149
Authors Title Published Journal PubMed Link
MacKinnon AC et al. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. 2002 J. Immunol. pmid:12444147
Osawa Y et al. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. 2001 J. Immunol. pmid:11418646
Lai WQ et al. The role of sphingosine kinase in a murine model of allergic asthma. 2008 J. Immunol. pmid:18322246
Lai WQ et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. 2008 J. Immunol. pmid:19017993
Manggau M et al. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. 2001 J. Invest. Dermatol. pmid:11710939
Walev I et al. Streptolysin O-permeabilized granulocytes shed L-selectin concomitantly with ceramide generation via neutral sphingomyelinase. 2000 J. Leukoc. Biol. pmid:11129654
Wong L et al. Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases. 2009 J. Med. Chem. pmid:19469544
Sun D and Hurley LH The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression. 2009 J. Med. Chem. pmid:19385599
Karliner JS et al. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. 2001 J. Mol. Cell. Cardiol. pmid:11549349
Asle-Rousta M et al. Prominence of central sphingosine-1-phosphate receptor-1 in attenuating aβ-induced injury by fingolimod. 2014 J. Mol. Neurosci. pmid:25239520
Saini HS et al. Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. 2005 J. Neurochem. pmid:16313513
Edsall LC et al. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. 2001 J. Neurochem. pmid:11238741
Jo JY et al. N,N-Dimethyl-D-erythro-sphingosine inhibits store-operated Ca2+ entry in U937 monocytes. 2008 J. Pharmacol. Sci. pmid:18635921
Lee EH et al. Dimethylsphingosine regulates intracellular pH and Ca(2+) in human monocytes. 2006 J. Pharmacol. Sci. pmid:16575153
Zhang YH et al. Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway. 2008 J. Physiol. (Lond.) pmid:18450779
Zhang YH et al. Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons. 2006 J. Physiol. (Lond.) pmid:16740613
Chan L Harnessing regulatory T cells for therapeutic purposes. 2012 Kidney Int. pmid:22543901
Lai LW et al. Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. 2012 Kidney Int. pmid:22189844
Pallis M Sphingosine kinase inhibitors in the apoptosis of leukaemia cells. 2002 Leuk. Res. pmid:11839389
Jendiroba DB et al. Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine. 2002 Leuk. Res. pmid:11792420
Kanno T and Nishizaki T Endogenous sphingosine 1-phosphate regulates spontaneous glutamate release from mossy fiber terminals via S1P(3) receptors. 2011 Life Sci. pmid:21683714
Van IJzendoorn SC et al. Polarized membrane traffic and cell polarity development is dependent on dihydroceramide synthase-regulated sphinganine turnover. 2004 Mol. Biol. Cell pmid:15229289
Wang H et al. N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. 2008 Mol. Cancer Ther. pmid:18790777
Lee YK et al. Multiple actions of dimethylsphingosine in 1321N1 astrocytes. 2007 Mol. Cells pmid:17464206
Nam JH et al. Sphingosine and FTY720 modulate pacemaking activity in interstitial cells of Cajal from mouse small intestine. 2013 Mol. Cells pmid:23912597
Lan T et al. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. 2011 Mol. Endocrinol. pmid:21998146
Kim HJ et al. Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action. 2007 Mol. Pharmacol. pmid:17504945
Trifilieff A et al. Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips. 2009 Naunyn Schmiedebergs Arch. Pharmacol. pmid:19636535
Hanafusa N et al. Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. 2002 Nephrol. Dial. Transplant. pmid:11917049
Chen YJ et al. Inflammation triggers production of dimethylsphingosine from oligodendrocytes. 2014 Neuroscience pmid:25151189
Kaneider NC et al. Leukocyte motility in response to neuropeptides is heparan sulfate proteoglycan dependent. 2003 Peptides pmid:12895655
Xia P et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9826677
Kim HL et al. Characterization of N,N,-dimethyl-D-erythro-sphingosine-induced apoptosis and signaling in U937 cells: independence of sphingosine kinase inhibition. 2008 Prostaglandins Other Lipid Mediat. pmid:18316219
Kim HL et al. Differential signaling of sphingosine derivatives in U937 human monocytes depends on the degree of N-methylation. 2008 Prostaglandins Other Lipid Mediat. pmid:18467142
Leroux ME et al. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. 2007 Prostate pmid:17879964
Kono Y et al. Sphingosine kinase 1 regulates mucin production via ERK phosphorylation. 2010 Pulm Pharmacol Ther pmid:19835973
Hobson JP et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. 2001 Science pmid:11230698
Itagaki K et al. Sphingosine kinase inhibition alleviates endothelial permeability induced by thrombin and activated neutrophils. 2010 Shock pmid:19851125
Leitzke AS et al. Isoflurane post-treatment ameliorates GMH-induced brain injury in neonatal rats. 2013 Stroke pmid:24149004
Igarashi Y [Bioregulatory functions of methylsphingosines: in relation to sphingolipid signaling pathway and on approach of introducing sphingolipid-based drugs]. 1998 Tanpakushitsu Kakusan Koso pmid:9528354
Ohmori T et al. The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2+ mobilization in platelets. 2005 Thromb. Res. pmid:15733975
Okamoto H et al. Sphingosine 1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration. 2000 Thromb. Res. pmid:10942792
Zhang Z et al. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma. 2015 Tumour Biol. pmid:25537088
Ren J et al. Expression of sphingosine kinase gene in the interactions between human gastric carcinoma cell and vascular endothelial cell. 2002 World J. Gastroenterol. pmid:12174364
Lei YC et al. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells. 2015 World J. Gastroenterol. pmid:26676341
Yu HM et al. [Regulation of sphingosine kinase 1 in the TNF-α-induced expression of MUC5AC in airway epithelial cells]. 2011 Zhonghua Yi Xue Za Zhi pmid:21418911
Yin GJ et al. [Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro]. 2012 Zhonghua Zhong Liu Za Zhi pmid:22780925
Liu SQ et al. [Sphingosine kinase 1 enhances the proliferation and invasion of human colon cancer LoVo cells through up-regulating FAK pathway and the expression of ICAM-1 and VCAM-1]. 2013 Zhonghua Zhong Liu Za Zhi pmid:24054007
Liu SQ et al. [Effect of sphingosine kinase 1 on the apoptosis, migration and invasion of colon cancer HT-29 cells and its molecular mechanisms]. 2011 Zhonghua Zhong Liu Za Zhi pmid:21575515